GlassScriptPhysician profile
Rachel J Cerchia
NPI 1578745519
$249.98
in general payments reported to CMS, 2019-2025
10 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.51 · 2023: $12.90 · 2024: $45.81 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $233.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $55.92 | 2021-2025 | Twinfix, Aetos Shoulder System, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Pacira Pharmaceuticals Incorporated | $39.59 | 2025 | Zilretta |
| Ferring Pharmaceuticals INC. | $32.86 | 2024-2025 | Euflexxa |
| Avanos Medical | $26.15 | 2025 | On-Q Pump and Accessories |
| Ossur Americas, INC. | $18.96 | 2025 | |
| Linvatec Corporation | $16.20 | 2025 | Biobrace 23mm |
| Fidia Pharma USA INC. | $16.07 | 2025 | Hymovis, Triluron |
| Depuy Synthes Sales INC. | $15.08 | 2024 | Monovisc, Orthovisc |
| Medacta USA, INC. | $14.84 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $14.31 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Cerchia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.